Alan Kwan

Alan Kwan joined QLS Advisors (“QLS”) in 2022 as the Head of Fundamental Research with responsibility for trading strategies innovation and the optimized integration of fundamental analysis into those strategies, where appropriate. Dr. Kwan previously served as an Analyst at Millennium Management, LLC where he designed, managed, and implemented semi-automated infrastructure to support several fundamentals-based trading strategies for his coverage in both large and SMID cap biopharma US equities. Prior to joining Millennium, Dr. Kwan served as a Vice President of Research at Tekla Capital Management where he covered both public and private healthcare investments. He received his B.S. in Computer Science from the University of British Columbia, his M.S. in Computer Science from Washington University in St. Louis, his Ph.D. in Computational Genomics from Washington University School of Medicine, and his MBA from MIT.